Daniel Lama

935 total citations
26 papers, 660 citations indexed

About

Daniel Lama is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Daniel Lama has authored 26 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 8 papers in Urology. Recurrent topics in Daniel Lama's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Pediatric Urology and Nephrology Studies (7 papers). Daniel Lama is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Pediatric Urology and Nephrology Studies (7 papers). Daniel Lama collaborates with scholars based in United States, Israel and Austria. Daniel Lama's co-authors include Peter K. Sand, Roger R. Dmochowski, Rodney U. Anderson, John R. Miklos, Rodney A. Appell, Daniel R. Saltzstein, Norman R. Zinner, Detlef Albrecht, Timothy B. Boone and David Staskin and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and The Journal of Urology.

In The Last Decade

Daniel Lama

24 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lama United States 12 471 374 286 141 114 26 660
Jean Nicolas Cornu France 12 399 0.8× 493 1.3× 204 0.7× 138 1.0× 244 2.1× 31 682
Hyeong Gon Kim South Korea 14 228 0.5× 238 0.6× 80 0.3× 183 1.3× 132 1.2× 57 522
Kevin Rademakers Netherlands 14 708 1.5× 704 1.9× 261 0.9× 142 1.0× 192 1.7× 33 881
Mayank Mohan Agarwal India 14 276 0.6× 160 0.4× 62 0.2× 95 0.7× 161 1.4× 33 440
E.S. Rovner United States 12 513 1.1× 611 1.6× 282 1.0× 49 0.3× 249 2.2× 123 753
Embert J. Messelink Netherlands 8 317 0.7× 334 0.9× 117 0.4× 51 0.4× 167 1.5× 9 906
Arjun Nambiar United Kingdom 18 877 1.9× 1.2k 3.1× 309 1.1× 295 2.1× 657 5.8× 48 1.5k
Montserrat Espuña‐Pons Spain 17 570 1.2× 970 2.6× 345 1.2× 34 0.2× 580 5.1× 52 1.2k
Alexander Gomelsky United States 7 448 1.0× 529 1.4× 201 0.7× 60 0.4× 238 2.1× 12 635
Gholamreza Mokhtari Iran 11 147 0.3× 86 0.2× 54 0.2× 134 1.0× 69 0.6× 31 330

Countries citing papers authored by Daniel Lama

Since Specialization
Citations

This map shows the geographic impact of Daniel Lama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lama more than expected).

Fields of papers citing papers by Daniel Lama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lama. The network helps show where Daniel Lama may publish in the future.

Co-authorship network of co-authors of Daniel Lama

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lama. A scholar is included among the top collaborators of Daniel Lama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lama. Daniel Lama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lama, Daniel, Ziyi Huang, Tania Contente‐Cuomo, et al.. (2025). Feasibility of enriched amplicon circulating tumor DNA sequencing to detect minimal residual disease (MRD) after prostatectomy in localized prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 402–402.
2.
Lama, Daniel, Mona Wahba, Abubakr Imam, et al.. (2025). SAME-DAY DISCHARGE AFTER ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY: A MULTI-INSTITUTIONAL ANALYSIS. Urologic Oncology Seminars and Original Investigations. 43(3). 73–74. 1 indexed citations
3.
Lama, Daniel, Jonathan Yamzon, Timothy G. Wilson, et al.. (2024). Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 43(4). 267.e19–267.e27. 1 indexed citations
5.
Sidana, Abhinav, et al.. (2024). Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer. Urologic Oncology Seminars and Original Investigations. 42(5). 158.e1–158.e10. 7 indexed citations
6.
Lama, Daniel, et al.. (2023). Long-term Outcomes and Patient Satisfaction Following Salvage Robot-assisted Radical Prostatectomy: A Modern Perspective. European Urology Open Science. 60. 1–7. 1 indexed citations
7.
Okhunov, Zhamshid, John Sung, Francis A. Jefferson, et al.. (2022). Prospective, Randomized Comparison of Dual-Lumen vs Single-Lumen Flexible Ureteroscopes in Proximal Ureteral and Renal Stone Management. Journal of Endourology. 36(7). 921–926. 5 indexed citations
8.
Lama, Daniel, et al.. (2022). Hundred years of transperineal prostate biopsy. Therapeutic Advances in Urology. 14. 3623447086–3623447086. 15 indexed citations
9.
Lama, Daniel, et al.. (2022). Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients?. The Aging Male. 25(1). 23–28. 1 indexed citations
10.
Lama, Daniel, et al.. (2021). Current Opinion Regarding Multidisciplinary Cancer Clinic Utilization for the Management of Prostate Cancer. Journal of Clinical Imaging Science. 11. 29–29. 2 indexed citations
12.
Verma, Sadhna, et al.. (2020). Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer. Prostate Cancer and Prostatic Diseases. 23(4). 567–572. 19 indexed citations
13.
Lama, Daniel, Roshan M. Patel, Thomas K. Lee, et al.. (2018). Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps. Urology. 117. 89–94. 25 indexed citations
14.
Lama, Daniel, et al.. (2018). Three-dimensional evaluation of perirenal fat volume in patients with nephrolithiasis. Urolithiasis. 46(6). 535–541. 11 indexed citations
15.
Lama, Daniel, et al.. (2018). Fluid Dynamic Analysis of Hand-Pump Infuser and UROMAT Endoscopic Automatic System for Irrigation Through a Flexible Ureteroscope. Journal of Endourology. 32(5). 431–436. 16 indexed citations
16.
Kaler, Kamaljot S., Daniel Lama, Zhamshid Okhunov, et al.. (2018). Medical impulsive therapy (MIT): the impact of 1 week of preoperative tamsulosin on deployment of 16-French ureteral access sheaths without preoperative ureteral stent placement. World Journal of Urology. 36(12). 2065–2071. 19 indexed citations
17.
Chu, Franklin, Roger R. Dmochowski, Daniel Lama, Rodney U. Anderson, & Peter K. Sand. (2005). Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: A subanalysis of data from the OPERA trial. American Journal of Obstetrics and Gynecology. 192(6). 1849–1854. 26 indexed citations
18.
Nickel, J. Curtis, John B. Forrest, Kevin M. Tomera, et al.. (2005). PENTOSAN POLYSULFATE SODIUM THERAPY FOR MEN WITH CHRONIC PELVIC PAIN SYNDROME: A MULTICENTER, RANDOMIZED, PLACEBO CONTROLLED STUDY. The Journal of Urology. 173(4). 1252–1255. 91 indexed citations
19.
Siami, Paul, Larry Seidman, & Daniel Lama. (2002). A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT). Clinical Therapeutics. 24(4). 616–628. 45 indexed citations
20.
Appell, Rodney A., Peter K. Sand, Roger R. Dmochowski, et al.. (2001). Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study. Mayo Clinic Proceedings. 76(4). 358–363. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026